247 related articles for article (PubMed ID: 18504578)
1. Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
Camci C; Sevinc A; Aslan Y; Kalender ME; Buyukberber S
Cancer Chemother Pharmacol; 2009 Mar; 63(4):745-8. PubMed ID: 18504578
[TBL] [Abstract][Full Text] [Related]
2. Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.
Gorumlu G; Kucukzeybek Y; Kemal-Gul M; Karaca B; Cosan-Terek M; Karabulut B; Sanli UA; Akman L; Ozsaran A; Dikmen Y; Uslu R
J BUON; 2008; 13(3):349-52. PubMed ID: 18979548
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.
Rose PG; Smrekar M; Haba P; Fusco N; Rodriguez M
Am J Clin Oncol; 2008 Oct; 31(5):476-80. PubMed ID: 18838885
[TBL] [Abstract][Full Text] [Related]
4. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
5. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Akiyama J; Sagara Y; Takeda Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
Samaritani R; Corrado G; Vizza E; Sbiroli C
BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
[TBL] [Abstract][Full Text] [Related]
7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
Harter P; Hilpert F; Mahner S; Heitz F; Pfisterer J; du Bois A
Expert Rev Anticancer Ther; 2010 Jan; 10(1):81-8. PubMed ID: 20014888
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy].
Chen JT; Nakayama K; Shimizu Y; Yokosuka K; Teshima H; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Hasumi K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):407-12. PubMed ID: 2106837
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
Wada Y; Suzuki M; Shinagawa S; Saito Y; Nishiya I; Maki M; Yajima A; Hiroi M; Sato A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
[TBL] [Abstract][Full Text] [Related]
11. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
Maki C; Groen J; Delgado B; Piura B
J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
[No Abstract] [Full Text] [Related]
12. [Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer].
Katase K; Shimizu Y; Kobayashi Y; Hasumi K
Gan To Kagaku Ryoho; 2004 Jun; 31(6):943-7. PubMed ID: 15222118
[TBL] [Abstract][Full Text] [Related]
13. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
[TBL] [Abstract][Full Text] [Related]
15. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
16. [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Sugawara T; Sakuramoto T; Fukushima S
Hinyokika Kiyo; 1987 Aug; 33(8):1232-5. PubMed ID: 3122543
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
Wu M; Shen K; Lang JH; Huang RL; Huang HF; Pan LY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1406-9. PubMed ID: 16029654
[TBL] [Abstract][Full Text] [Related]
18. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer chemotherapy.
Christian J; Thomas H
Cancer Treat Rev; 2001 Apr; 27(2):99-109. PubMed ID: 11319848
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]